Efficacy and Tolerability of Atorvastatin as Add on Therapy in the Treatment of Chronic Stable (Moderate-Severe) Asthma for a Duration of 8 Weeks

International Journal of Basic & Clinical Pharmacology
doi 10.5455/2319-2003.ijbcp20131223
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medip Academy

Related search

Reslizumab: Add-On Therapy for Severe Eosinophilic Asthma

Prescriber
Pharmacology
2017English

Omalizumab as Add‐on Therapy in a Patient With Severe Asthma and OSA

Respirology Case Reports
PulmonaryRespiratory Medicine
2020English

Efficacy and Safety Observed During 24 Weeks of Efalizumab Therapy in Patients With Moderate to Severe Plaque Psoriasis

Archives of Dermatology
2005English

Study of Efficacy, Safety & Tolerability of Oral Isotretinoin in Patients of Moderate to Severe Acne Vulgaries

Journal of Evolution of Medical and Dental Sciences
2014English

A Phase III Randomized Controlled Trial of Tiotropium Add-On Therapy in Children With Severe Symptomatic Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Efficacy and Safety of Dupilumab for the Treatment of Moderate-To-Severe Atopic Dermatitis in Adults

Oncotarget
Oncology
2017English

Safety and Tolerability of Low-Dose Naltrexone Therapy in Children With Moderate to Severe Crohn’s Disease

Journal of Clinical Gastroenterology
Gastroenterology
2013English

The Effectiveness of Local Atorvastatin in the Treatment of Moderate Periodontitis

International Journal of Advanced Research
2019English

Dupilumab Efficacy and Safety in Moderate-To-Severe Uncontrolled AsthmaEfficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

Pediatrics
Child HealthPediatricsPerinatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy